Filter
24
Filtered Results: 24
Text search:
Human
T-cell
lymphotropic
virus
Type
1
Featured
Recommendations
3
New Publications
9
Language
Document type
No document type
15
Guidelines
6
Studies & Reports
2
Training Material
1
Countries / Regions
Ghana
1
Nigeria
1
Ethiopia
1
India
1
Authors & Publishers
Publication Years
Category
General Guidelines
2
Guidelines
2
Capacity Building
2
HIV & STI
2
Disease Prevention & Control
2
Hematology
1
Pediatrics
1
Medical Devices & Equipment
1
Policies & Guidelines HIV & TB
1
Drugs & Medical Equipment
1
Statistics
1
Quality Control & Assurance
1
Communicable Diseases
1
Toolboxes
Laboratory
4
Testing Guidelines
4
Gynaecology / Obstetrics
1
IPC
1
Treatment & Prevention
1
Children & Adolescents
1
Treatment Guidelines HIV
1
Men who have sex with men (MSM)
1
Infection Control General
1
Blood Supply
1
Essential Medicines & Devices Lists
1
General documents One Health
1
Overview, Studies & Reports
1
Others
1
Paediatrics
1
HIV in Key Populations
1
Pregnant women
1
J Acquir Immune Defic Syndr Volume 78, Supplement 1, August 15, 2018
PQDx 0181-031-00
WHO PQ Public Report
March/2017, version 3.0
Eurosurveillance
Impact Factor 5.7
June 2015
www.eurosurveillance.org
Featuring a series of articles on HIV and STI epidemiology, prevention and control among MSM in Europe
PQDx 0006-005-00 WHO
PQDx PR
February/2016, version 2.0
The updated List of Essential Diagnostics contains 46 general tests that can be used for routine patient care as well as for the detection and diagnosis of a wide array of disease conditions, and 69 tests intended for the detection, diagnosis and monitoring of specific diseases.
The List is divid...
ECDC Technical Report
In line with ECDC’s recommendations provided in the ’Risk Assessment of HTLV-1/2 transmission by tissue/cell transplantation’ dated 14 March 2012, this Directive replaces the term ‘incidence’ with ‘prevalence’ in the description of endemic areas of HTLV-1/2 i...
In line with ECDC’s recommendations provided in the ’Risk Assessment of HTLV-1/2 transmission by tissue/cell transplantation’ dated 14 March 2012, this Directive replaces the term ‘incidence’ with ‘prevalence’ in the description of endemic areas of HTLV-1/2 i...
The provision of safe and efficacious blood and blood components for transfusion or manufacturing use involves a number of processes, from the selection of blood donors and the collection, processing and testing of blood donations to the testing of patient samples, the issue of compatible blood and ...
PQDx 0198-071-00
WHO PQDx PR
April/2016, version 2.0
3rd Edition – July 2017
www.msfaccess.org
published in: Viruses 2016, 8, 161
Provide guidance to HIV care practitioners on the optimal use of antiretroviral (ARV) agents for the treatment of HIV infection in adults and adolescents.
2018
9th Edition
Offering information on HIV/AIDS treatment, prevention, and research
In line with its decentralization principle, the Ethiopian Health Policy has achieved great progress in improving access to comprehensive HIV/AIDS services to the majority of the population. Both quality and coverage of services have improved significantlysince the initiation...
2nd edition, June 2021
Infectious diseases continue to impose unpredictable burdens on global health and economies, a subject that requires constant research and updates. In this sense, the objective of the present article was to review studies on the role of wild animals as reservoirs and/or dispersers of etiological age...
WHO guideline on preventive chemotherapy for public health control of strongyloidiasis
recommended
Human strongyloidiasis is a chronic parasitic disease caused by infection with Strongyloides stercoralis, a soil-transmitted helminth that is estimated to infect 300–600 million people worldwide. This neglected tropical disease (NTD) is endemic globally, predominately in the South-East Asia, Afric...
